Camostat Withdrawn Phase 4 Trials for COVID / Coronavirus Disease 2019 (COVID‑19) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04338906 | Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19 |